Volume 22 Issue 7
Jul.  2024
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2024  >  22(7): 1102-1107
ZHANG Zongbing, LE Zhenghong, LIU Mulin, HAO Bo. Expression of ITGB2 in gastric cancer and its clinical value[J]. Chinese Journal of General Practice, 2024, 22(7): 1102-1107. doi: 10.16766/j.cnki.issn.1674-4152.003576
Citation: ZHANG Zongbing, LE Zhenghong, LIU Mulin, HAO Bo. Expression of ITGB2 in gastric cancer and its clinical value[J]. Chinese Journal of General Practice, 2024, 22(7): 1102-1107. doi: 10.16766/j.cnki.issn.1674-4152.003576
shu

Expression of ITGB2 in gastric cancer and its clinical value

doi: 10.16766/j.cnki.issn.1674-4152.003576

  • Department of Gastrointestinal Surgery, the First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233004, China

Funds:

 2108085MH291

  • Received Date: 2024-01-07
    Available Online: 2024-09-05
    Abstract
  •   Objective  To investigate the expression of ITGB2 in gastric cancer tissues and its correlation with malignant progression of gastric cancer, and to analyze the possible biological processes of ITGB2 by bioinformatics.  Methods  The expression level of ITGB2 in gastric cancer tissues and its correlation with malignant progression of gastric cancer were analyzed using online database. A total of 107 patients with gastric cancer who received radical gastrectomy in the First Affiliated Hospital of Bengbu Medical University from February 2016 to December 2018 were included. The expression of ITGB2 in gastric cancer tissues and its effect on the prognosis of patients with gastric cancer were analyzed. The biological processes and signaling pathways involved in ITGB2 were analyzed using DAVID database. TIMER2.0 database was used to explore the potential relationship between ITGB2 expression and various immune cell infiltration.  Results  Immunohistochemical results showed that ITGB2 was highly expressed in gastric cancer tissues (3.465±1.037 in gastric cancer tissues and 1.000±0.271 in para-cancerous tissues, t=22.653, P < 0.001). The results of qRT-PCR test confirmed that the mRNA level of ITGB2 in gastric cancer tissue was significantly higher than that in paracancer tissue (P < 0.001). Western blotting test further verified the above experimental results. The survival rate of patients with high ITGB2 expression group was lower than that of patients with low ITGB2 expression group (log-rank χ2=38.394, P < 0.001). Univariate and multivariate analysis showed that high expression of ITGB2 in gastric cancer tissue, CEA≥5 μg/L in peripheral blood, CA19-9≥37 kU/L, clinical T3-T4 and N2-N3 (P < 0.05) were independent risk factors affecting the prognosis of patients with gastric cancer. Bioinformatic analysis showed that ITGB2 was involved in the regulation of immune response.  Conclusion  ITGB2 is highly expressed in gastric cancer and is involved in the malignant evolution of gastric cancer, which is closely related to the poor prognosis and immune cell infiltration of patients with gastric cancer.

     

    • FullText(HTML)
  • loading
    • References(17)
  • [1]
    SMYTH E C, NILSSON M, GRABSCH H I, et al. Gastric cancer[J]. Lancet, 2020, 396(10251): 635-648. doi: 10.1016/S0140-6736(20)31288-5
    [2]
    LORDICK F, CARNEIRO F, CASCINU S, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up[J]. Ann Oncol, 2022, 33(10): 1005-1020. doi: 10.1016/j.annonc.2022.07.004
    [3]
    SETO Y. Sarcopenia, muscle quality, and gastric cancer surgery[J]. Ann Gastroenterol Surg, 2021, 5(4): 402-403. doi: 10.1002/ags3.12485
    [4]
    KUBOTA T, SHODA K, KONISHI H, et al. Nutrition update in gastric cancer surgery[J]. Ann Gastroenterol Surg, 2020, 4(4): 360-368. doi: 10.1002/ags3.12351
    [5]
    LIU D P, ZHANG B X, MATSUNAGA T, et al. A comparison of gastric cancer surgery between Japan and China[J]. Yonago Acta Med, 2019, 62(4): 268-272. doi: 10.33160/yam.2019.11.001
    [6]
    杨子, 张浩, 徐梦宇, 等. 胃癌中MLF1IP表达的预后价值及其对肿瘤进展的调控作用[J]. 四川大学学报(医学版), 2023, 54(1): 114-121. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYK202301019.htm

    YANG Z, ZHANG H, XU M Y, et al. Prognostic value of the expression of myeloid leukemia factor 1-interacting protein in gastric cancer and its regulatory role in tumor progression[J]. Journal of Sichuan University(Medical Sciences), 2023, 54(1): 114-121. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYK202301019.htm
    [7]
    LUO C L, XIAO X Y, LIU D H, et al. CABYR is a novel cancer-testis antigen in lung cancer[J]. Clin Cancer Res, 2007, 13(4): 1288-1297. doi: 10.1158/1078-0432.CCR-06-1742
    [8]
    JOSHI S S, BADGWELL B D. Current treatment and recent progress in gastric cancer[J]. CA Cancer J Clin, 2021, 71(3): 264-279. doi: 10.3322/caac.21657
    [9]
    XU H S, ZHANG A K, HAN X Y, et al. ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas[J]. Cancer Immunol Immunother, 2022, 71(3): 645-660. doi: 10.1007/s00262-021-03022-2
    [10]
    FUJITA T. Gastric cancer[J]. Lancet, 2009, 374(9701): 1593-4. DOI: 10.1016/S0140-6736(09)61946-2.
    [11]
    张朝阳, 杨子, 李洪涛, 等. CD13在胃癌中的表达与临床病理参数的关系及其对远期预后的预测价值[J]. 中华全科医学, 2023, 21(12): 2018-2021. doi: 10.16766/j.cnki.issn.1674-4152.003280

    ZHANG C Y, YANG Z, LI H T, et al. The relationship between CD13 expression and clinicopathological parameters in gastric cancer and its predictive value for long term prognosis[J]. Chinese Journal of General Practice, 2023, 21(12): 2018-2021. doi: 10.16766/j.cnki.issn.1674-4152.003280
    [12]
    SUN J G, SHEN D D, ZHENG Y C, et al. USP8 inhibitor suppresses HER-2 positive gastric cancer cell proliferation and metastasis via the PI3K/AKT signaling pathway[J]. Onco Targets Ther, 2020, 13: 9941-9952. doi: 10.2147/OTT.S271496
    [13]
    GEORGE L, MENDEN H, XIA S, et al. ITGB2 (Integrin β2) immunomodulatory gene variants in premature infants with necrotizing enterocolitis[J]. J Pediatr Gastroenterol Nutr, 2021, 72(2): e37-e41.
    [14]
    WEI J, HUANG X J, HUANG Y, et al. Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia[J]. Ann Transl Med, 2021, 9(17): 1386. DOI: 10.21037/atm-21-3641.
    [15]
    HUTTERER E, ASSLABER D, CALDANA C, et al. CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and -independent mechanisms[J]. Br J Haematol, 2015, 169(2): 286-289. doi: 10.1111/bjh.13188
    [16]
    DASHTI N, MAHMOUDI M, GHARIBDOOST F, et al. Evaluation of ITGB2 (CD18) and SELL (CD62L) genes expression and methylation of ITGB2 promoter region in patients with systemic sclerosis[J]. Rheumatol Int, 2018, 38(3): 489-498. doi: 10.1007/s00296-017-3915-y
    [17]
    SUN Z Q, DANG Q, LIU Z Q, et al. LINC01272/miR-876/ITGB2 axis facilitates the metastasis of colorectal cancer via epithelial-mesenchymal transition[J]. J Cancer, 2021, 12(13): 3909-3919. doi: 10.7150/jca.55666
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (63) PDF downloads(8) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return